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Abstract
Major burn injury induces T-lymphocyte dysfunction. Previous studies suggest that prostaglandin (PG) E2, which is
elevated post-burn, is the causative factor via a cyclic AMP-dependent process. The present study was conducted to elucidate
the mechanism by which cAMP induces T-lymphocyte dysfunction following burn injury. Splenocytes were isolated from
mice 7 days after receiving a scald burn covering 25% of their total body surface or sham procedure. ConA-induced
proliferation by splenocytes from burned mice was significantly suppressed. Macrophage depletion of the splenocyte cultures
abrogated the suppression. Concanavalin A-stimulated proliferation by macrophage-depleted splenocytes was suppressed by
PGE2 and dibutyryl cAMP in both groups. The IC50 of these cAMP-elevating agents, however, was approximately 100-fold
lower for cells from burned mice, indicating an increased sensitivity to cAMP. PGE2 did not suppress PMA/Ca2 ionophore-
induced T-lymphocyte activation. Addition of PMA to ConA-stimulated cultures prevented the suppression of proliferative
responses by PGE2, whereas Ca2 ionophore had no effect. Thus, the suppression of T-lymphocyte activation following burn
injury is macrophage-dependent, related to an increased sensitivity to cAMP and due to an uncoupling of cell surface
receptors from protein kinase C activation. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
A critical aspect of the host response to thermal
injury is the hyperproduction of arachidonic acid
metabolites (i.e., prostaglandins, leukotrienes, throm-
boxanes) which have profound immunomodulatory
properties [1^3]. With regards to prostaglandins,
prostaglandin E2 (PGE2) has been previously shown
to suppress T-lymphocyte function at the level of
lymphoproliferative responses and interleukin-2 (IL-
2) productive capacity [4,5]. It is thought that the
suppressive e¡ects of PGE2 on T-lymphocyte func-
tion is via the generation of high and sustained levels
of intracellular cyclic AMP (cAMP). This notion is
supported by observations that other agents that el-
evate intracellular cAMP (i.e., dibutyryl cAMP, for-
skolin, cholera toxin) induce similar aspects of cellu-
lar depression [5,6].
Thermal injury has been shown to induce a
marked depression in cellular immune responses
both clinically [3,7] and in animal studies [8^10]. Fur-
thermore, the impairment of lymphocyte function
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following burn trauma correlates with the severity of
the injury and susceptibility to subsequent sepsis and
multiple organ failure [11,12]. The mediators and
mechanisms responsible for this immune dysfunction
have remained controversial, as previous studies have
implicated a range of factors including, Th-2 cyto-
kines (e.g., IL-4, IL-10) [13], nitric oxide [8] and
prostanoids [3,9,10]. Nonetheless, the relationship
between PGE2 and thermal injury-induced immune
dysfunction is compelling based on the following ob-
servations: (1) systemic PGE2 is elevated following
burn injury [14]; (2) macrophages isolated from
burned hosts produced increased amounts of PGE2
[2,15]; (3) inhibitors of cyclooxygenase can restore
some aspects of T-lymphocyte function [3,10]; and
(4) peripheral blood mononuclear cells from burn
victims are more sensitive to the inhibitory e¡ects
of PGE2 [3].
It appears that PGE2-mediated suppression of
T-lymphocyte function is through the activation of
adenylate cyclase and increased intracellular cAMP
levels. Even though the intracellular mediator (i.e.,
cAMP) has been identi¢ed, the mechanism by which
it exerts its suppressive e¡ects on T-lymphocyte func-
tion remains unclear. Furthermore, it is unknown if
the response of T lymphocytes to elevated intracellu-
lar cAMP is altered by thermal injury. With regard
to an altered response to cAMP in immune cells fol-
lowing thermal injury, studies by Molloy et al. [16]
and our laboratory [17] have shown that macrophage
responses to cAMP were altered at the level of TNF-
K and nitric oxide productive capacity. Additionally,
Grbic et al. [3] have shown that T lymphocytes from
burn patients are more sensitive to the inhibitory
e¡ects of PGE2. It is not clear, however, whether
this is due to elevated intracellular cAMP levels in
response to PGE2, increased sensitivity to cAMP, or
both. Therefore, the present study was undertaken to
elucidate the mechanism(s) by which PGE2 and
cAMP suppress T-lymphocyte function and whether
or not thermal injury alters this response.
2. Materials and methods
2.1. Animals
C57BL/6 female mice (18^20 g; 8^10 weeks of age,
Charles River) were used for all experiments. The
mice allowed to acclimatized to the animal facility
for at least 1 week prior to experimentation. No
attempt was made to determine their stage of estrus
prior to experimentation. The experiments in this
paper were approved by the Institutional Animal
Care and Use Committee of Rhode Island Hospital,
and performed in accordance with the National In-
stitutes of Health guidelines for the care and han-
dling of laboratory animals.
2.2. Experimental groups
The mice were randomly assigned into either a
thermal injury group or a sham treatment group.
Three to seven mice per group were used for each
condition.
2.3. Thermal injury procedure
Mice received a third-degree full-thickness scald
burn as previously described [8,17,18]. Brie£y, the
mice were anesthetized by intraperitoneal (i.p.) injec-
tion of 65 mg/kg body wt. sodium pentobarbital and
the entire dorsal surface was shaved. The animal was
placed in a custom insulated mold that exposed
12.5% of the total body surface area (TBSA) along
the dorsum and immersed in 70‡C water for 7 s. The
procedure was repeated on the opposite side of the
dorsum yielding a 25% TBSA burn. The mice were
then resuscitated with 2 ml of sterile PBS adminis-
tered i.p. and returned to their cages. The cages were
placed on a heating pad (set on medium) for 2 h.
Once the mice were fully awake they were returned
to the animal facility. Sham treatment was identical
with the exception that the dorsum was exposed to
tepid water. Lethality in this thermal injury model
was not signi¢cant.
2.4. Preparation of splenocytes
The mice were sacri¢ced by methoxy£urane over-
dose at 7 days after injury and the spleens were re-
moved aseptically. Splenocyte suspensions were pre-
pared in complete media (RPMI-1640 containing
10% heat-inactivated FBS, 50 WM L-mercaptoetha-
nol, and 5 Wg/ml gentimycin; Gibco BRL, Grand
Island, NY) as described elsewhere [8,17]. Spleno-
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cytes were depleted of macrophages (MPs) by pas-
sage over Sephadex G-10 (Sigma Chemical) [19,20]
and resuspended in complete media at a concentra-
tion of 1U107 cells/ml.
2.5. In vitro treatment with PGE2 or dibutyryl cAMP
Splenocyte cultures were established and PGE2 (0^
1000 ng/ml; 0^2.84 WM) (Calbiochem, San Diego,
CA) or dibutyryl cAMP (adenosine 3P,5P cyclic
monophosphate N6,O2P dibutyryl-, sodium salt; db-
cAMP) (0^100 WM) (Calbiochem) were added to the
cultures immediately prior to stimulation of prolifer-
ation or IL-2 production.
2.6. T-Lymphocyte proliferation
T-Lymphocyte proliferation was assessed in re-
sponse to 5 Wg/ml Concanavalin A (ConA) (Sigma)
or 10 ng/ml phorbol myristate acetate (PMA) in
combination with 0.3 WM calcium ionophore
A23187 (Calbiochem). 5U105 cells/well (¢nal vol-
ume = 200 Wl) were incubated for 30 h prior to the
addition of 1 WCi of [3H]thymidine (speci¢c activity
6.7 Ci/mmol, New England Nuclear, Cambridge,
MA) per well. The [3H]thymidine pulsed cells were
incubated for an additional 18 h and harvested onto
glass-¢ber mats. L-Decay was detected by liquid scin-
tillation radiography. Data are expressed as
cpmU1033. Radioactivity associated with cells not
receiving any stimulation was consistently less than
1% of the maximal cpm incorporated in response to
ConA, anti-CD3, or PMA and A23187 stimulation
and not subtracted from the proliferation values.
2.7. IL-2 production
The capacity of T lymphocytes to secrete immu-
noreactive IL-2 was determined by enzyme-linked
immunosorbemt assay (ELISA). The cells were cul-
tured at a concentration of 2.5U106 cells/ml for 24 h
and cell-free supernatants were harvested and frozen
at 370‡C until determination of IL-2 levels by sand-
wich ELISA using a matched pair of monoclonal
antibodies according to the manufacturer’s instruc-
tions (PharMingen, San Diego, CA).
2.8. Cell staining and £ow cytometric analysis
Splenocytes were stained with the combination of
antibodies conjugated to either £uorescein isothio-
cyanate (FITC), phycoerythrin (PE) or Cy-Chrome
as previously described by Ayala et al. [21]. Brie£y,
1U106 splenocytes were incubated with 10 Wg Fc
Block (PharMingen)/ml PBS for 15 min at 4‡C.
The cells were washed by centrifugation and incu-
bated in the dark for 45 min (4‡C) with 100 Wl
PBS containing either 200 ng each of monoclonal
rat anti-mouse CD45R/B220, isotype IgG2a conju-
gated to Cy-Chrome (PharMingen) and monoclonal
hamster anti-mouse CD3O, isotype IgG, group 1, U
conjugated to FITC (PharMingen) or 200 ng each of
monoclonal rat anti-mouse CD4, isotype IgG2a, U
conjugated to PE (PharMingen) and monoclonal
rat anti-mouse CD8a, isotype IgG2a, U conjugated
to Cy-Chrome (PharMingen). The cells were washed
by centrifugation and ¢xed overnight (4‡C) with 1%
paraformaldehyde in PBS. Following ¢xation the
cells were washed and resuspended in PBS. Isotype
controls (e.g., Cy-Chrome- and PE-conjugated rat
IgG2a, FITC-conjugated hamster IgG, PharMingen)
were included to assess non-speci¢c staining and
gated out appropriately. FITC, PE, and Cy-Chrome
were excited by an argon laser set at 488 nm, but
detection of FITC £uorescent emission was with a
530 þ 15 nm wide bandpass ¢lter, PE £uorescent
emission was with a 575 þ 13 nm dichroic ¢lter and
Cy-Chrome £uorescent emission was with a 650
long-pass ¢lter on a Becton^Dickinson FACSort
£ow cytometer (San Jose, CA). No less than 20 000
cells were assessed per sample. PC-Lysis Ver. 1.0
software (Becton^Dickinson) was used to establish
four regions in dual stained dot plots: (1) double
negative, (2) single positive (e.g., PE), (3) single pos-
itive (e.g., Cy-Chrome), and (4) double positive.
2.9. Statistical analysis
Data are expressed as mean þ S.E.M. for 3^7 ex-
periments. Comparisons were analyzed using stu-
dent’s t-test or the Mann^Whitney U-test for multi-
ple comparisons. A P value of less than 0.05 was
considered to be statistically signi¢cant.
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3. Results
3.1. The role of macrophages in the suppression of
splenic T-lymphocyte proliferation post-injury
The results shown in Fig. 1 indicate that thermal
injury induced a profound suppression (approxi-
mately 85%) of the proliferative response of unfrac-
tionated splenocytes to ConA. Depletion of macro-
phages (MPs) from the splenocyte populations,
however, completely abrogated the suppression in
the thermal injury group. Proliferative responses of
MP-depleted splenocytes from sham treated mice
were not signi¢cantly di¡erent from unfractionated
splenocytes.
3.2. Cyclic AMP-mediated suppression T-lymphocyte
activation
PGE2 treatment dose-dependently suppressed
ConA-stimulated proliferation of MP-depleted sple-
nocytes from both sham and injured mice (Fig. 2A).
However, the suppressive e¡ects of PGE2 were great-
er in the injury group. Statistically signi¢cant
(P6 0.05) suppression was observed in the injury
group at all concentrations of PGE2 evaluated
(0.1^1000 ng/ml; 2.84 pM^2.84 WM). In contrast,
the suppression of proliferation by cells from sham
mice was only signi¢cant at PGE2 concentrations of
10^1000 ng/ml. Furthermore, PGE2 also had signi¢-
cantly greater suppressive e¡ects (P6 0.05) at any
given concentration on cells from injured mice. In
this regard, the IC50 concentration of PGE2 for the
sham group was 1570 ng/ml (4.46 WM), whereas the
IC50 for injury group was 6.8 ng/ml (0.02 WM). db-
cAMP also suppressed ConA-stimulated prolifera-
Fig. 1. ConA-stimulated proliferation of splenocyte fractions.
Splenocytes were isolated from sham and burned (injury) mice
as described in Section 2. Macrophages were depleted by pas-
sage over a G-10 sephadex column (MP-depleted) or left intact
(unfractionated) and stimulated with ConA. Data are mean þ
S.E.M. from three experiments. *P6 0.05 as compared to
sham.
Fig. 2. Suppression of ConA-stimulated proliferation by cAMP-
elevating agents. Macrophage-depleted splenocytes from sham
or burned (injury) mice were stimulated with ConA in the pres-
ence of various concentrations of either PGE2 (A) or db-cAMP
(B) and proliferative responses measured. Data are mean þ
S.E.M. from 5^7 (A) or 4^5 (B) experiments. *P6 0.05 as com-
pared to cells not treated with PGE2 (0 ng/ml) (A) or db-
cAMP (0 WM) (B). 2P6 0.05 as compared to cells from sham
mice treated with the same concentration of PGE2 (A) or db-
cAMP (B).
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tion in both cell populations (Fig. 2B). The suppres-
sive e¡ects of db-cAMP on cells from injured mice
were signi¢cant (P6 0.05) at concentrations of 10^
100 WM and cells from sham treated mice were only
suppressed at the highest concentration of db-cAMP
(100 WM). The calculated IC50 for db-cAMP were
1.5 mM and 11.9 WM for the sham and injury
groups, respectively.
Thermal injury did not signi¢cantly alter the abil-
ity of MP-depleted splenocytes to secrete IL-2 (Fig.
3). PGE2 treatment caused a dose-dependent sup-
pression in IL-2 productive capacity that was com-
parable in both cells from sham and injured mice.
The suppressive e¡ect of PGE2 was signi¢cant
(P6 0.05) at concentrations of 10^1000 ng/ml and
maximal suppression (1000 ng/ml PGE2) was ap-
proximately 50% in both groups. Treatment of the
cells with db-cAMP also resulted in a dose-depend-
ent suppression of IL-2 secretory capacity, and no
di¡erence was observed between the sham and injury
groups (Fig. 3B). Maximal suppression (100 WM db-
cAMP) was approximately 70^75% in both groups.
3.3. The e¡ect of thermal injury on splenocyte
phenotype
Total splenocyte yields were not signi¢cantly af-
fected by thermal injury (approximately 12^13U107
cells per spleen for both sham and burned animals).
Splenocytes from sham and injured mice were char-
acterized for the expression of surface antigens using
£ow cytometric analysis as shown in a representative
experiment in Fig. 4. Thermal injury did not alter the
percentage of CD3 cells found in the spleen (com-
pare Fig. 4A with B). The percentage of B220 cells,
however, was reduced following thermal injury (Fig.
4A cf. B). The percentage of cells not staining for
these T- and B-lymphocyte surface antigens was ap-
proximately doubled following thermal injury. None-
theless, increase in double-negative staining in the
injured group was not statistically signi¢cant.
The T-lymphocyte fraction of the splenocytes was
evaluated further for the expression of the T-lympho-
cyte antigens CD4 and CD8. Thermal injury induced
minimal changes in the percentage of CD4 and
CD8 cells in the spleen (Fig. 4C as compared to D).
3.4. PGE2-mediated suppression of T lymphocyte
proliferation is independent of IL-2
The ConA-stimulated proliferative response of
MP-depleted splenocytes in the presence of exoge-
nous IL-2 (1^10 U/ml) was assessed. The addition
of IL-2 did not prevent the suppression of ConA-
induced proliferation in either the sham or the injury
groups (Table 1).
Fig. 3. Suppression of ConA-stimulated IL-2 production by
cAMP-elevating agents. Macrophage-depleted splenocytes from
sham or burned (injury) mice were stimulated with ConA in
the presence of various concentrations of either PGE2 (A) or
db-cAMP (B). Cell-free supernatants were collected 24 h later
and IL-2 concentrations measured by ELISA as described in
Section 2. Data are mean þ S.E.M. from 5^7 (A) or 6^7 (B) ex-
periments. *P6 0.05 as compared to cells not treated (0) with
either PGE2 (A) or db-cAMP (B).
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3.5. PGE2-mediated suppression of T-lymphocyte
activation is proximal to intracellular signaling
events
In order to determine whether or not the PGE2-
mediated suppression of T-lymphocyte activation
was due to changes in calcium signaling and protein
kinase C (PKC) activation, the response of MP-de-
pleted splenocytes to PMA (10 ng/ml) in combina-
tion with calcium ionophore (A23187, 0.3 WM) was
assessed. PGE2 treatment did not suppress prolifer-
ative responses (Fig. 5A) or IL-2 production (Fig.
5B) by either cell population. The dependency of
the PGE2-induced defect on cell surface-mediated
events was further con¢rmed by the observation
that anti-CD3 stimulated proliferation was signi¢-
cantly (P6 0.05) suppressed by PGE2 treatment
(100 ng/ml) (Fig. 5C).
The proliferative response of MP-depleted spleno-
cytes to ConA in the presence of calcium ionophore
(A23187) was assessed. The addition of A23187
(50 nM) to the culture media did not prevent the
PGE2-induced suppression of proliferation in either
the sham or the injury groups (Fig. 6A). A23187 did
not induce proliferation in the absence of ConA.
Higher concentrations of A23187 (500 nM), while
inducing low levels of proliferation (approximately
4^6U103 cpm), also completely inhibited the re-
sponse to ConA (data not shown). In contrast, the
addition of PMA (2.5 ng/ml) to the culture media
prevented the PGE2-induced suppression of ConA-
induced proliferation in both cell populations (Fig.
6B). This concentration of PMA also induced low
levels of proliferation, independent of ConA
(V16U103 cpm) that were signi¢cantly lower
(P6 0.05) than the response to ConA alone or in
combination with PMA.
4. Discussion
Severe burn injury causes a pronounced immuno-
suppression and increases the risk to subsequent sep-
sis and multiple organ failure [12,17]. A number of
mediator(s) and mechanism(s) responsible for this
immune dysfunction have been implicated [8,13] in-
Table 1
The e¡ect of IL-2 on ConA-stimulated proliferation of macrophage-depleted splenocytes
IL-2 (U/ml) Proliferation (cpmU103)a
Sham Injury
3PGE2 +PGE2 3PGE2 +PGE2
0 96.6 þ 7.9b 71.0 þ 5.1* 85.0 þ 5.8 53.1 þ 10.1*
1 94.9 þ 4.8 74.9 þ 4.0* 79.4 þ 7.5 51.8 þ 9.8*
10 99.0 þ 8.3 77.7 þ 2.1* 82.0 þ 8.2 60.2 þ 16.3*
aMP-depleted splenocytes were stimulated with ConA in the absence (3PGE2) or presence of 100 ng/ml PGE2 (+PGE2).
bData are mean þ S.E.M. for three experiments.
*P6 0.05 as compared to respective group not treated with PGE2, but treated with the same concentration of IL-2.
Fig. 4. Splenic lymphocyte phenotype. Splenocytes from sham
or burned (injury) mice were subjected to two-color £ow cyto-
metric analysis for cell surface antigens as described in Section
2. Expression of the T-lymphocyte marker CD3O (x-axis) and
the B-lymphocyte marker B220 (y-axis) for splenocytes from
sham and burned mice are shown in panels A and B, respec-
tively. Expression of the T-lymphocyte markers CD4 (x-axis)
and CD8 (y-axis) for splenocytes from sham and burned mice
are shown in panels C and D, respectively. Percentages in se-
lected quadrants of each panel represent the percentage of the
total splenocyte population. Data are from a representative ex-
periment of three.
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cluding prostanoids [1,3]. The observation that the
thermal injury-induced suppression of splenic T-lym-
phocyte proliferative responses was dependent upon
the presence of MPs in the mixed cell culture is con-
sistent with clinical studies by De et al. [22] in which
a subset of trauma patients had normal T-lympho-
cyte responses in the absence of MPs. Previous stud-
ies have demonstrated that cAMP-elevating agents
(i.e., PGE2) can suppress receptor-mediated activa-
tion of T lymphocytes, independent of injury [4^6].
Our ¢ndings indicated that T lymphocytes from in-
jured animals were signi¢cantly more sensitive to the
immunosuppressive e¡ects of PGE2 as well as the
cAMP analog, db-cAMP. Thus, the increased sensi-
tivity to PGE2-mediated suppression following ther-
Fig. 5. E¡ect of PGE2 on T-lymphocyte activation induced by
PMA and calcium ionophore or anti-CD3. Macrophage-de-
pleted splenocytes from sham or burned (injury) mice were
stimulated with PMA and calcium ionophore (A23187) (A and
B) or surface bound anti-CD3 (C) in the absence (control) or
presence of PGE2 (100 ng/ml), and proliferation (A,C) or IL-2
productive capacity (B) were measured as described in Section
2. Data are mean þ S.E.M. for 3^6 experiments. *P6 0.05 as
compared to cells not treated with PGE2.
Fig. 6. E¡ect of restoration of calcium or PKC signaling on
PGE2-mediated suppression of ConA-stimulated proliferation.
Macrophage-depleted splenocytes from sham or burned (injury)
mice were stimulated with ConA in the absence (3) or presence
(+) of PGE2 (100 ng/ml), calcium ionophore A23187 (50 WM)
(A) and PMA (2.5 ng/ml) (B). Data are mean þ S.E.M. for 3^4
experiments. *P6 0.05 as compared with respective group not
treated with PGE2.
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mal injury cannot be simply explained by a greater
elevation in intracellular cAMP levels [9], but rather
appears to be related to an alteration in cAMP-de-
pendent signal transduction pathways. The cAMP-
induced suppression appeared to be proximal to the
activation of protein kinase C (PKC), since restora-
tion of PKC signaling with exogenous PMA abro-
gated the suppression. Therefore, the cAMP-induced
defect in T-lymphocyte activation following thermal
injury may be related to an uncoupling between T-
cell receptor ligation and subsequent activation of
PKC signaling by diacylglycerol (DAG).
Previous studies have shown that CD8 T lym-
phocytes are more sensitive to the inhibitory e¡ects
of PGE2 than CD4 T lymphocytes [23]. Moreover,
prior activation of T lymphocytes markedly in-
creased the sensitivity to PGE2 [23]. Our ¢ndings
indicate that the increased sensitivity to cAMP-in-
duced suppression of proliferative responses follow-
ing thermal injury was independent of changes in
splenic T-lymphocyte subsets, since percentages of
CD4 and CD8 cells were not altered by burn in-
jury. Thus, the increased sensitivity of T lymphocytes
from burned animals to cAMP may be related to
earlier activation in vivo in response to the injury.
Alternatively, the increased sensitivity to cAMP may
also be related to di¡erences in IL-10 production,
since previous studies have shown that thermal injury
induces a Th-2 response with elevated IL-10 produc-
tion [13]. In this regard, IL-10 has suppressive e¡ects
on cell mediated immunity and its expression is en-
hanced by cAMP-elevating agents (i.e., PGE2, db-
cAMP) [24]. The decrease in the percentage of
B220 cells (B lymphocytes) following thermal injury
appears to be due to an apparent increase in the
number of cells negative for T- and B-lymphocyte
markers. These double-negative cells are most likely
predominantly macrophages. This notion, however,
needs to be con¢rmed.
PGE2 also alters the interactions between antigen
presenting cells (APC) and T lymphocytes by inhib-
iting the class II major histocompatibility complex
expression [25]. Furthermore, antigen presentation
is suppressed following burn injury [26] and other
forms of trauma [27]. Thus, the depression in antigen
presentation by PGE2 under such conditions may
contribute to the suppression of T-lymphocyte acti-
vation. Since macrophages were depleted from the
splenocyte cultures in the present study, B cells are
the probable APC. It is not known, however, if B-cell
APC function is compromised following thermal in-
jury.
In contrast to our ¢nding here, O’Riordain et al.
[28] have shown that addition of exogenous IL-2
restored splenic lymphocyte proliferative responses
following thermal injury. The apparent discrepancy
between our ¢ndings and O’Riordain et al. [28] may
be related the higher concentration of IL-2 used (i.e.,
100 U/ml) and/or the use of unfractionated spleno-
cytes (macrophages, T cells and B cells) in their
study.
Cyclic-AMP mediates most of its e¡ects via acti-
vation of cAMP-dependent kinases (PKA) leading to
phosphorylation of intracellular proteins. A number
of di¡erent cell surface receptor/ligand interactions
(e.g., PGE2 and L-adrenergic) can elevate intracellu-
lar cAMP. Studies infer that cAMP levels (via PGE2)
are elevated in immune cells following thermal injury
[3,9] and that enhanced adenylate cyclase activity in
response to receptor activation is responsible for the
functional alteration. Horgan et al. [9] have shown
that the thermal injury-induced suppression in sple-
nocyte IL-2 productive capacity was not evident
when PKC-Ca2 signaling was stimulated directly
with PMA and calcium ionophore. Moreover, Faist
et al. [29] have shown that the defect in mitogen
stimulated IL-2 synthesis by peripheral blood mono-
nuclear cells (PBMC) from trauma patients is attrib-
utable to alterations in signal transduction pathways
that were restorable with PKC activation. In con-
trast, alterations in Ca2 signaling have been impli-
cated in the suppression of T-lymphocyte activation
by PGE2 [4].
Our ¢ndings suggest that the thermal injury-in-
duced signaling defect in T lymphocytes was related
to activation of PKC rather than alterations in Ca2
signaling pathways, consistent with previous ¢ndings
[29,30]. Thus, suggesting that by directly activating
PKC, thus bypassing the early activation events fol-
lowing receptor cross-linking, normal T-lymphocyte
activation can occur. Nonetheless, a role for Ca2 in
the T-lymphocyte signaling defect following thermal
injury cannot be ruled out, since the PKC and Ca2
signaling pathways are interrelated. Furthermore, the
Ca2 and PKC signal transduction pathways can
also interact through cAMP in the following ways:
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(1) [Ca2]i and cAMP can modulate each other’s
levels through Ca2-calmodulin dependent regulation
of adenylate cyclase/phosphodiesterase activity; (2)
PKC can be phosphorylated by cAMP-dependent
PKA; (3) PKC and PKA can phosphorylate the
same protein, thereby di¡erentially regulating its ac-
tivity. While PGE2 and cAMP may a¡ect [Ca2]i
homeostasis in T lymphocytes, the e¡ect of thermal
injury on PKC activity appears to be the critical
factor in the suppression of proliferative responses
under such conditions. The mechanism by which
cAMP-mediated suppression of T-lymphocyte activa-
tion occurs may be related to phosphatidylinositol
turnover [31], inhibition of phospholipase C activity
[32], and/or increased binding activity of nuclear pro-
tein AP-1 [33]. Our speculation is that the alteration
in cAMP sensitivity involves dysfunctional activation
of phospholipase C following ligand^receptor bind-
ing, resulting in decreased DAG generation and re-
duced PKC activation. Nonetheless, further studies
are required to determine the precise alterations in T-
lymphocyte signal transduction that contribute to an
increased sensitivity to cAMP-induced suppression
following thermal injury.
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